BPH: unmet needs in managing LUTS--a European perspective
- PMID: 22124306
- DOI: 10.1038/nrurol.2011.190
BPH: unmet needs in managing LUTS--a European perspective
Similar articles
-
Surgery for benign prostatic hyperplasia: Profile of patients in a tertiary care institution.Natl Med J India. 2017 Jan-Feb;30(1):7-10. Natl Med J India. 2017. PMID: 28730999
-
[Medical combination therapy in LUTS suggestive of BPH].Urologe A. 2009 Mar;48(3):250-6. doi: 10.1007/s00120-008-1919-7. Urologe A. 2009. PMID: 19212753 Review. German.
-
Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy.Eur J Cancer Prev. 2002 Oct;11(5):473-9. doi: 10.1097/00008469-200210000-00010. Eur J Cancer Prev. 2002. PMID: 12394245
-
Under what conditions is feedback microwave thermotherapy (ProstaLund Feedback Treatment) cost-effective in comparison with alpha-blockade in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms?Scand J Urol Nephrol. 2006;40(6):495-505. doi: 10.1080/00365590600830409. Scand J Urol Nephrol. 2006. PMID: 17130102
-
[Treatment of LUTS in BPS. When and when not to administer pills?].Urologe A. 2009 Mar;48(3):257-63. doi: 10.1007/s00120-009-1980-x. Urologe A. 2009. PMID: 19296071 Review. German.
Cited by
-
Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy).Healthcare (Basel). 2022 Dec 17;10(12):2567. doi: 10.3390/healthcare10122567. Healthcare (Basel). 2022. PMID: 36554090 Free PMC article.
-
Quality of Life in Older Adults with Benign Prostatic Hyperplasia.Healthcare (Basel). 2020 Jun 4;8(2):158. doi: 10.3390/healthcare8020158. Healthcare (Basel). 2020. PMID: 32512888 Free PMC article.
-
Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009-2016.Medicine (Baltimore). 2022 Sep 9;101(36):e30091. doi: 10.1097/MD.0000000000030091. Medicine (Baltimore). 2022. PMID: 36086750 Free PMC article.
-
Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia.Int Urol Nephrol. 2023 Apr;55(4):845-851. doi: 10.1007/s11255-023-03476-6. Epub 2023 Feb 10. Int Urol Nephrol. 2023. PMID: 36763223
-
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?BMC Urol. 2015 Sep 21;15:96. doi: 10.1186/s12894-015-0090-x. BMC Urol. 2015. PMID: 26391357 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical